Genome wide loss of heterozygosity (LOH) is associated with dysfunctional HR and sensitivity to PARP inhibitors; LOH occurs in MM and is indeed associated with dysfunctional HR in a subset of patients (135). The gene discussed is PARP1; the disease is Miyoshi myopathy.